Live
- Alliance candidates set to sweep in Anakapalli, says Defence Minister Rajnath Singh
- All depts coordination meet held for Haj 2024
- Ex-RBI Guv launches book on his life journey
- Cyberabad police bust diesel smuggling gang
- Hyderabad: Workshop held on preventing wildlife crimes
- Pulivendula: Countdown for Jagan’s fall began, says Ravi
- ‘Many bureaucrats still working as YSRCP activists’
- Sec'bad Cantt bypoll: Residents root for merger with GHMC to end woes
- Timetable out for Adv Suppl exams
- 22 TSREIS Jr colleges record 100% pass
Dr Reddy’s responds to USFDA on quality issues
City-based Dr Reddy\'s Laboratories on Wednesday said it had submitted a response to the US health regulator on a warning letter it had received last month.
Hyderabad: City-based Dr Reddy's Laboratories on Wednesday said it had submitted a response to the US health regulator on a warning letter it had received last month.
"We would like to inform that the company has submitted a response to the US Food and Drug Administration (USFDA) on December 7", the pharma major said in a release.
Last month, the company received a warning letter from the USFDA relating to quality control issues at two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana.
In the warning letter, the US health regulator had asked the drug maker to provide a comprehensive evaluation of the extent of inaccuracies in recorded and reported data and include a detailed action plan to fully investigate the scale and root causes of ‘deficient documentation and data management practices’.
